Cite
HARVARD Citation
Aklillu, E. et al. (2021). Early or deferred initiation of efavirenz during rifampicin‐based TB therapy has no significant effect on CYP3A induction in TB‐HIV infected patients. British journal of pharmacology. pp. 3294-3308. [Online].